Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes
Part of paid clinical trials in Walnut Creek, California.
- Sponsor
- Regeneron Pharmaceuticals
- Study ID
- NCT07685808
- Phase
- PHASE2
- Status
- Recruiting
Conditions
- Overweight or Obesity
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Olatorepatide — DRUGAdministered per the protocol
- Placebo — DRUGAdministered per the protocol
Study Details
This study will test an experimental drug called olatorepatide ("study drug") to determine how safe and effective this drug is compared to placebo and how easily the body can accept this drug at different doses and dosing schedules without causing side effects, as well as how the drug is processed in the body by participants with overweight or obesity but do not have diabetes. The study is looking at: * What side effects the study drug might cause * How much study drug is in the blood at different times * How well the study drug works * What effects the study drug may have on the body at different dosing schedules * If the body makes antibodies to the study drug as this may cause the study drug to not work as well
Key Dates
- First listed
- Jul 6, 2026
- Start date
- Jul 28, 2026
- Status verified
- Aug 2026
- Primary completion
- Jan 21, 2028
- Completion
- Jan 21, 2028
Study Design
- Enrollment
- 360 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Olatorepatide arm 1
- Experimental: Olatorepatide arm 2
- Experimental: Olatorepatide arm 3
- Experimental: Olatorepatide arm 4
- Experimental: Olatorepatide arm 5
- Active Comparator: Matching Placebo arm 6
Primary Outcome Measure
Occurrence of Treatment-Emergent Adverse Events (TEAEs) [ Time Frame: Up to approximately 60 weeks ]
Central Contacts
- Clinical Trials Administrator844-734-6643
Locations (5)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Diablo Clinical Research - Flourish Research | Walnut Creek | California | 94598 | - |
| K2 Medical Research Maitland LLC, Main Office | Maitland | Florida | 32751 | - |
| Charter Research LLC - The Villages | The Villages | Florida | 32162 | - |
| Clinical Site Partners, LLC DBA Flourish Research | Winter Park | Florida | 32789 | - |
| AMR Clinical - Lexington | Lexington | Kentucky | 40509 | - |
Find similar trials in Walnut Creek, CA
Related Studies
- eMOTION: Examining Affective Mechanisms in Physical Activity EngagementRecruiting · University of Southern California · Los Angeles, California
- Community Park-Based Programs for Health Promotion: The Fit2Lead Prospective Cohort StudyRecruiting · Duke University · Miami, Florida
- A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)PHASE4 · Recruiting · Eli Lilly and Company · Phoenix, Arizona
- A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)PHASE4 · Recruiting · Eli Lilly and Company · Avondale, Arizona